Publications (48) JESÚS MIGUEL PRADILLO JUSTO publications

2024

  1. The role of gut microbiota in cerebrovascular disease and related dementia

    British Journal of Pharmacology, Vol. 181, Núm. 6, pp. 816-839

2023

  1. Defective hippocampal neurogenesis underlies cognitive impairment by carotid stenosis-induced cerebral hypoperfusion in mice

    Frontiers in Cellular Neuroscience, Vol. 17

  2. Neutrophil β1 adrenoceptor blockade blunts stroke-associated neuroinflammation

    British Journal of Pharmacology, Vol. 180, Núm. 4, pp. 459-478

2022

  1. Del laboratorio a la clínica en el ictus isquémico agudo. Modelos experimentales in vitro e in vivo

    Revista de neurologia, Vol. 75, Núm. 9, pp. 283-293

2021

  1. Influence of metabolic syndrome on post-stroke outcome, angiogenesis and vascular function in old rats determined by dynamic contrast enhanced MRI

    Journal of Cerebral Blood Flow and Metabolism, Vol. 41, Núm. 7, pp. 1692-1706

2019

  1. Pharmacological Modulation of Neutrophil Extracellular Traps Reverses Thrombotic Stroke tPA (Tissue-Type Plasminogen Activator) Resistance

    Stroke, Vol. 50, Núm. 11, pp. 3228-3237

  2. Toll-like receptor 4 regulates subventricular zone proliferation and neuroblast migration after experimental stroke

    Brain, Behavior, and Immunity, Vol. 80, pp. 573-582

2018

  1. Aspectos moleculares de la interacción de los fármacos con sus dianas farmacológicas

    Velázquez. Farmacología básica y clínica (Editorial Médica Panamericana), pp. 63-94

  2. Multi-modal imaging of long-term recovery post-stroke by positron emission tomography and matrix-assisted laser desorption/ionisation mass spectrometry

    Rapid Communications in Mass Spectrometry, Vol. 32, Núm. 9, pp. 721-729

  3. Myeloid cells as therapeutic targets in neuroinflammation after stroke: Specific roles of neutrophils and neutrophil–platelet interactions

    Journal of Cerebral Blood Flow and Metabolism, Vol. 38, Núm. 12, pp. 2150-2164

  4. TLR4-Binding DNA Aptamers Show a Protective Effect against Acute Stroke in Animal Models

    Molecular Therapy, Vol. 26, Núm. 8, pp. 2047-2059

2017

  1. Cannabinoid type-2 receptor drives neurogenesis and improves functional outcome after stroke

    Stroke, Vol. 48, Núm. 1, pp. 204-212

  2. Cytokines and Chemokines in Stroke

    Primer on Cerebrovascular Diseases: Second Edition (Elsevier Inc.), pp. 280-284

  3. Reparative effects of interleukin-1 receptor antagonist in young and aged/co-morbid rodents after cerebral ischemia

    Brain, Behavior, and Immunity, Vol. 61, pp. 117-126

  4. Specific Features of SVZ Neurogenesis after Cortical Ischemia: A Longitudinal Study

    Scientific Reports, Vol. 7, Núm. 1

  5. Toll-Like Receptor 4 Mediates Hemorrhagic Transformation after Delayed Tissue Plasminogen Activator Administration in In Situ Thromboembolic Stroke

    Stroke, Vol. 48, Núm. 6, pp. 1695-1699

2016

  1. A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in stroke

    Journal of Cerebral Blood Flow and Metabolism, Vol. 36, Núm. 3, pp. 596-605

  2. Mechanisms of Comorbidities Associated With the Metabolic Syndrome: Insights from the JCR:LA-cp Corpulent Rat Strain

    Frontiers in Nutrition, Vol. 3

2015

  1. 18F-GE-180: a novel TSPO radiotracer compared to 11C-R-PK11195 in a preclinical model of stroke

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 42, Núm. 3, pp. 503-511

  2. Aging increases microglial proliferation, delays cell migration, and decreases cortical neurogenesis after focal cerebral ischemia

    Journal of Neuroinflammation, Vol. 12, Núm. 1, pp. 1